Jen-Chieh Lee Selected Research

Jen-Chieh Lee Research Topics

Disease

31	Neoplasms (Cancer) 07/2022 - 08/2008
5	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 04/2010
5	Diarrhea 01/2022 - 12/2014
5	Infections 12/2021 - 01/2013
4	Intellectual Disability (Idiocy) 12/2015 - 02/2015
4	Thalassemia 12/2015 - 02/2015
3	Diabetes Mellitus 01/2022 - 04/2015
3	Disease Progression 01/2022 - 12/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2022 - 10/2010
3	Clostridium Infections 01/2022 - 12/2014
2	Adenocarcinoma 01/2022 - 01/2017
2	Leiomyosarcoma 01/2022 - 06/2017
2	Cytomegalovirus Infections (Inclusion Disease) 06/2015 - 12/2014
2	Bacteremia 12/2014 - 10/2013
1	Dengue (Dengue Fever) 04/2022
1	COVID-19 02/2022
1	Aspergillosis 01/2022
1	Keloid 01/2022
1	Myoepithelioma 01/2022
1	Angiomatoid Fibrous Histiocytoma 01/2022
1	Endometrial Stromal Sarcoma 01/2022
1	Ileus 12/2021
1	Toxic Megacolon 12/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neurofibrosarcoma (MPNST) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Familial Hypophosphatemia (Phosphate Diabetes) 10/2018
1	Abdominal Pain (Pain, Abdominal) 04/2018
1	Necrosis 01/2018
1	Communicable Diseases (Infectious Diseases) 08/2017
1	Smooth Muscle Tumor 06/2017
1	Leiomyoma (Uterine Fibroids) 06/2017
1	Giant Cell Tumors (Giant Cell Tumor) 01/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2008
6	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2017
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 06/2015
5	Proton Pump InhibitorsIBA 04/2021 - 04/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2010
3	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 01/2013
3	Vancomycin FDA LinkGeneric 12/2021 - 01/2013
2	MART-1 AntigenIBA 07/2022 - 01/2019
2	AzolesIBA 01/2022 - 09/2015
2	CollagenIBA 01/2022 - 01/2020
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 01/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 08/2015
2	ChromatinIBA 11/2019 - 08/2015
2	Oncogene Proteins (Oncogene Protein)IBA 02/2017 - 08/2008
2	ParaffinIBA 01/2017 - 01/2016
2	ran-binding protein 2IBA 08/2015 - 12/2008
2	AntibodiesIBA 06/2015 - 04/2010
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2015 - 12/2014
1	AntigensIBA 04/2022
1	Viral RNAIBA 04/2022
1	Immunoglobulin M (IgM)IBA 04/2022
1	nirmatrelvirIBA 02/2022
1	nirmatrelvir and ritonavir drug combinationIBA 02/2022
1	VaccinesIBA 02/2022
1	MyogeninIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	NivolumabIBA 01/2022
1	Biological ProductsIBA 01/2022
1	DesminIBA 01/2022
1	CDTA (DCTA)IBA 12/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2021
1	RO 3306IBA 01/2021
1	EnzymesIBA 01/2021
1	naringinIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	cordycepinIBA 01/2021
1	Adenosine DeaminaseIBA 01/2021
1	Pentostatin (Nipent)FDA LinkGeneric 01/2021
1	TubulinIBA 01/2021
1	Claudin-1IBA 01/2020
1	Keratins (Keratin)IBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	S100 Proteins (S 100 Protein)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	Calbindin 2IBA 01/2019
1	LipidsIBA 01/2019
1	Inhibins (Inhibin)IBA 01/2019
1	liposomal doxorubicin (Doxil)FDA Link 01/2019
1	Fibroblast Growth Factor 1 (FGF-1)IBA 10/2018
1	NucleotidesIBA 01/2017
1	Histones (Histone)IBA 01/2017

Therapy/Procedure

11	Therapeutics 02/2022 - 03/2012
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
5	Length of Stay 12/2021 - 08/2015
2	Radiotherapy 01/2022 - 04/2010
2	Aftercare (After-Treatment) 09/2019 - 04/2010
2	Colectomy 01/2018 - 01/2016
1	Secondary Prevention 02/2022
1	Radiofrequency Ablation 01/2022
1	Thrombectomy 10/2021
1	Adjuvant Radiotherapy 09/2019